UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Nature communications, 2019-11, Vol.10 (1), p.5114-5114, Article 5114

2019

Volltextzugriff (PDF)

Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non―Small Cell Lung Cancer Cells

Clinical cancer research, 2013-02, Vol.19 (4), p.845-854

2013

Volltextzugriff (PDF)

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Cancer cell, 2018-04, Vol.33 (4), p.752-769.e8

2018

Volltextzugriff (PDF)

Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer

Thoracic cancer, 2024-03, Vol.15 (7), p.529-537

2024

Volltextzugriff (PDF)

Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma

Journal of the European Academy of Dermatology and Venereology, 2023-02, Vol.37 (2), p.328-339

2023

Volltextzugriff (PDF)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Scientific reports, 2023-11, Vol.13 (1), p.20323-20323, Article 20323

2023

Volltextzugriff (PDF)

Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.7049-7058

2016

Volltextzugriff (PDF)

Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case–control cohort study

International journal of dermatology, 2021-02, Vol.60 (2), p.179-184

2021

Volltextzugriff (PDF)

Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads

Current issues in molecular biology, 2022-05, Vol.44 (5), p.2374-2386

2022

Volltextzugriff (PDF)

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

Environmental health, 2024-03, Vol.23 (1), p.29-29, Article 29

2024

Volltextzugriff (PDF)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation

Frontiers in immunology, 2022-10, Vol.13, p.1011092-1011092

2022

Volltextzugriff (PDF)

CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia

Genetic testing and molecular biomarkers, 2016-12, Vol.20 (12), p.732-740

2016

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers

Cancer cell, 2013-06, Vol.23 (6), p.796-810

2013

Volltextzugriff (PDF)

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab

Cancers, 2022-07, Vol.14 (14), p.3470

2022

Volltextzugriff (PDF)

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Therapeutic advances in medical oncology, 2024, Vol.16, p.17588359231222604-17588359231222604

2024

Volltextzugriff (PDF)

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

Thoracic cancer, 2019-05, Vol.10 (5), p.1158-1166

2019

Volltextzugriff (PDF)

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Nature communications, 2020-01, Vol.11 (1), p.673-673, Article 673

2020

Volltextzugriff (PDF)

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

Vaccines (Basel), 2024-05, Vol.12 (5), p.474

2024

Volltextzugriff (PDF)

Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer

Frontiers in immunology, 2018-02, Vol.9, p.232-232

2018

Volltextzugriff (PDF)

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer

Thoracic cancer, 2018-12, Vol.9 (12), p.1648-1655

2018

Volltextzugriff (PDF)

MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis

The Journal of clinical investigation, 2014-07, Vol.124 (7), p.3093-3106

2014

Volltextzugriff (PDF)

AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1451-1462

2016

Volltextzugriff (PDF)

Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b⁺/CD14⁻/CD15⁺/CD33⁺ myeloid-derived suppressor cells and CD8⁺ T lymphocytes in patients with advanced-stage non-small cell lung cancer

Journal of cancer research and clinical oncology, 2010, Vol.136 (1), p.35-45

2010

Volltextzugriff (PDF)

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations

Oncotarget, 2017-11, Vol.8 (57), p.97602-97612

2017

Volltextzugriff (PDF)

Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients

Cancer genomics & proteomics, 2020-07, Vol.17 (4), p.417-423

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(75)

Sprache

Englisch
(67)
Koreanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non―Small Cell Lung Cancer Cells

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer

Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation

Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case–control cohort study

Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation

CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia

Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer

MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis

AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation

Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b⁺/CD14⁻/CD15⁺/CD33⁺ myeloid-derived suppressor cells and CD8⁺ T lymphocytes in patients with advanced-stage non-small cell lung cancer

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations

Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients

Suchergebnisse filtern